Butterfly network

Butterfly Network Reports First Quarter 2024 Financial Results

Retrieved on: 
Mercredi, mai 1, 2024

Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced financial results for the first quarter ended March 31, 2024, and provided a business update.

Key Points: 
  • Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced financial results for the first quarter ended March 31, 2024, and provided a business update.
  • We are so encouraged by our first quarter results that we are confidently increasing our guidance for 2024.
  • Received EU MDR Certification for Butterfly iQ+: On March 20, 2024, Butterfly announced the attainment of its EU MDR certificate for the Butterfly iQ+ ultrasound system.
  • A conference call and webcast to discuss first quarter 2024 financial results and operational progress is scheduled for 5:00 pm ET on May 1, 2024.

Butterfly Network to Report First Quarter 2024 Financial Results on May 1, 2024

Retrieved on: 
Mercredi, avril 17, 2024

Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report first quarter 2024 financial results on May 1, 2024, after the market closes.

Key Points: 
  • Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report first quarter 2024 financial results on May 1, 2024, after the market closes.
  • Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast at 5:00 pm ET on May 1, 2024, to discuss first quarter 2024 financial results and operational progress.
  • Individuals interested in listening to the conference call on your telephone may do so by dialing approximately ten minutes prior to start time:
    After the live webcast, the call will be archived on Butterfly’s Investor Relations page.
  • In addition, a telephone replay of the call will be available until May 15, 2024, by dialing:

Butterfly Network, Clinton Health Access Initiative, and Global Ultrasound Institute Partner to Advance Maternal and Fetal Health in South Africa

Retrieved on: 
Lundi, avril 15, 2024

As of today, the organizations have initiated Phase Two of Butterfly's 1,000 iQ+ probe deployment and point-of-care ultrasound training program for maternal and fetal health in Sub-Saharan Africa.

Key Points: 
  • As of today, the organizations have initiated Phase Two of Butterfly's 1,000 iQ+ probe deployment and point-of-care ultrasound training program for maternal and fetal health in Sub-Saharan Africa.
  • View the full release here: https://www.businesswire.com/news/home/20240415955318/en/
    Healthcare workers in Eastern Cape, South Africa enrolled in a week-long Butterfly point-of-care ultrasound training program.
  • "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa.
  • We look forward to working closely with Butterfly Network and the Global Ultrasound Institute to achieve our shared goal of advancing global health equity."

Increased Adoption of Artificial Intelligence Across the Healthcare Industry Driving Strong Market Growth

Retrieved on: 
Mercredi, mars 27, 2024

In diagnostics, AI enables healthcare providers to make the most appropriate treatment decisions for their patients.

Key Points: 
  • In diagnostics, AI enables healthcare providers to make the most appropriate treatment decisions for their patients.
  • Mordor Intelligence continued: “The increased prevalence of cancer and the high burden of other chronic diseases are, in turn, increasing the demand for accurate diagnosis and treatment.
  • This is likely to increase the adoption of AI for early diagnosis purposes, ultimately boosting the market growth.
  • The use of artificial intelligence in the North American healthcare market is being driven by the increasing use of advanced technology in healthcare systems, the growth in funding of AI-based startups, the rising burden of chronic diseases in the country, the growing need to reduce healthcare costs, and the implementation of big data in healthcare.

Myomo Appoints Heather Getz to its Board of Directors

Retrieved on: 
Jeudi, mars 28, 2024

Ms. Getz brings more than 25 years of corporate experience creating long-term value through financial, general management, and healthcare leadership.

Key Points: 
  • Ms. Getz brings more than 25 years of corporate experience creating long-term value through financial, general management, and healthcare leadership.
  • “We welcome Heather to the Myomo board of directors,” said Paul R. Gudonis, chairman and chief executive officer of Myomo.
  • "She brings financial and operational experience in scaling medical device and technology companies, which will be valuable to the board of directors as Myomo accelerates its growth."
  • “I am excited to join the Myomo board at such a pivotal time in the company’s history.

Syllo Bolsters Leadership Team with Appointments of Eric Wall and Oz Ben-Ami

Retrieved on: 
Mardi, mars 26, 2024

Syllo , the litigation platform for the AI era , today announced the appointments of Eric Wall, Executive Vice President, and Oz Ben-Ami, Head of Platforms.

Key Points: 
  • Syllo , the litigation platform for the AI era , today announced the appointments of Eric Wall, Executive Vice President, and Oz Ben-Ami, Head of Platforms.
  • Ben-Ami, who started at Syllo in late 2023, steers Syllo’s strategies around platform and secure deployment.
  • Wall previously served as CEO of Equivity, which provides dedicated virtual assistant services to individuals and organizations.
  • “We are excited to welcome Eric and Oz to Syllo.

Butterfly Network Announces Successful Investor Day

Retrieved on: 
Mardi, mars 19, 2024

Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, hosted its first investor day under President, Chief Executive Officer and Chairman, Joseph DeVivo.

Key Points: 
  • Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, hosted its first investor day under President, Chief Executive Officer and Chairman, Joseph DeVivo.
  • Also included in the event were innovative showcases on Butterfly iQ3™, Butterfly Compass™ Software and Butterfly Vet, as well as strategic Powered by Butterfly™ partners ( Forest Neurotech , Mendaera ) and select Butterfly Garden™ partners ( Deepecho , iCardio.ai , ThinkSono , University of North Carolina School of Medicine ) introducing AI applications and novel products that are in co-development.
  • “The goal of our Investor Day was to show stakeholders that Butterfly’s success is inevitable.
  • A webcast replay of the event will be available on Butterfly’s Events & Presentations page on the investor relations website.

Butterfly Network Announces Investor Day

Retrieved on: 
Vendredi, mars 15, 2024

Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, will host its previously announced Investor Day on Monday March 18, 2024, beginning at 12:00pm ET at the New York Stock Exchange.

Key Points: 
  • Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, will host its previously announced Investor Day on Monday March 18, 2024, beginning at 12:00pm ET at the New York Stock Exchange.
  • A live audio webcast of the event will be available beginning at approximately 12:00pm ET, and will be available on Butterfly’s Events & Presentations page on the investor relations website.
  • An audio replay of the event will be available following the event on Butterfly’s Events & Presentations page on the investor relations website.

Butterfly Network to Participate at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Retrieved on: 
Mercredi, mars 6, 2024

Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that Joseph DeVivo, President, Chief Executive Officer and Chairman, and Heather Getz, Executive Vice President, Chief Financial and Operations Officer, will participate in a fireside chat and host one-on-one investor meetings at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference on March 13, 2024, at 8:40 am ET.

Key Points: 
  • Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that Joseph DeVivo, President, Chief Executive Officer and Chairman, and Heather Getz, Executive Vice President, Chief Financial and Operations Officer, will participate in a fireside chat and host one-on-one investor meetings at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference on March 13, 2024, at 8:40 am ET.
  • The conference will be held virtually.
  • A webcast of the fireside chat will be available in the Events & Presentations section of the Butterfly investor website, and available for replay following the event until June 11, 2024.
  • To schedule a one-on-one meeting with Mr. DeVivo and Ms. Getz, please reach out to your Oppenheimer representative.

Butterfly Network Reports Fourth Quarter 2023 Financial Results

Retrieved on: 
Mercredi, février 28, 2024

Mendaera Agreement: On December 19, 2023, Butterfly announced an agreement to commercialize a novel robotic system that is Powered by Butterfly’s Ultrasound-on-Chip™ technology.

Key Points: 
  • Mendaera Agreement: On December 19, 2023, Butterfly announced an agreement to commercialize a novel robotic system that is Powered by Butterfly’s Ultrasound-on-Chip™ technology.
  • Forest Neurotech Agreement: On October 24, 2023, Butterfly announced that it had entered into a five-year co-development agreement with Forest Neurotech.
  • Three Months Ended December 31, 2023 Financial Results
    Revenue: Total revenue was $16.5 million, down from $19.0 million in the fourth quarter of 2022.
  • An explanation of these non-GAAP financial measures is also included below under the heading “Non-GAAP Financial Measures.”
    A conference call and webcast to discuss the fourth quarter and full year 2023 financial results and operational progress is scheduled for 5:00 pm ET, February 28, 2024.